Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829296 · ClinicalTrials.gov registry record · Phase 2
Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries
A Phase 2 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00829296: Completed Phase 2 study, sponsored by University of Chicago.
NCT00829296 is a Phase 2 study that has completed, run by University of Chicago. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829296, a Phase 2 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The study is being done to see if a drug shown to lower the risk of heart failure is also effective in reducing the stiffness of the arteries.
Primary Outcome
Changes in aortic impedance in patients on nebivolol vs. metoprolol succinate in Type 2 hypertensive diabetic patients as measured by the change from baseline in central systolic blood pressure.
Interventions
- DRUG Metoprolol
- DRUG nebivolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-04 |
| Phase | Phase 2 |
What the finished NCT00829296 record still lists
NCT00829296 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 2 interventions - of which Metoprolol is the first listed.
NCT00829296 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829296 about?
NCT00829296 is a clinical study titled "Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries". The study is being done to see if a drug shown to lower the risk of heart failure is also effective in reducing the stiffness of the arteries.
What is the current status of trial NCT00829296?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2009-01. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00829296?
The interventions under investigation include: Metoprolol (DRUG), nebivolol (DRUG).
Who is sponsoring clinical trial NCT00829296?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829296's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia